GlaxoSmithKline (GSK) has got green light from the Food and Drug Administration (FDA) for using a drug combination to treat melanoma, the deadliest form of skin cancer. The US regulator has approved GSK for the combined use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib for melanoma medication. The FDA approval was announced late on Wednesday. It is noteworthy that the … [Read more...]
You are here: Home / Archives for GSK melanoma drug